Tic disorder

Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy

Retrieved on: 
Dienstag, Mai 28, 2024

“The formation of this Clinical Advisory Board marks a major development step for Satellos as we continue our evolution in becoming a clinical stage drug development company,” said Frank Gleeson, Co-founder and CEO of Satellos.

Key Points: 
  • “The formation of this Clinical Advisory Board marks a major development step for Satellos as we continue our evolution in becoming a clinical stage drug development company,” said Frank Gleeson, Co-founder and CEO of Satellos.
  • Research in his laboratory focuses on utilizing genome editing technologies like CRISPR for the development of therapeutic approaches for neurogenetic disorders.
  • Francesco Muntoni, M.D., Director, Dubowitz Neuromuscular Centre, Great Ormond Street UCL Institute of Child Health, is focused on advancing novel therapeutics in translational and clinical research for pediatric neuromuscular disorders, especially Duchenne muscular dystrophy.
  • Dr. Shieh’s principal clinical interests include Duchenne muscular dystrophy (DMD), facioscapulohumeral muscular dystrophy (FSHD), and myotonic dystrophy.

GlutenFree.MPWH.com - Exclusive Dating Platform for Gluten-Free Singles

Retrieved on: 
Donnerstag, Mai 23, 2024

To help this special community find like-minded partners and avoid the awkwardness and inconvenience of dating, GlutenFree.MPWH.com has emerged.

Key Points: 
  • To help this special community find like-minded partners and avoid the awkwardness and inconvenience of dating, GlutenFree.MPWH.com has emerged.
  • GlutenFree.MPWH.com is a dating platform specifically designed for gluten-free singles.
  • "Our goal is to provide a platform where gluten-free singles can connect, find companionship, and build relationships based on mutual understanding and care."
  • GlutenFree.MPWH.com is the premier online platform for gluten-free singles, dedicated to creating genuine connections.

Kellanova recognizes Mental Health Awareness Month with Learning Resource

Retrieved on: 
Montag, Mai 13, 2024

CHICAGO, May 13, 2024 /PRNewswire/ -- In recognition of Mental Health Awareness Month, Kellanova continues to provide education and resources to support employees' mental health, including Made Academy.

Key Points: 
  • CHICAGO, May 13, 2024 /PRNewswire/ -- In recognition of Mental Health Awareness Month, Kellanova continues to provide education and resources to support employees' mental health, including Made Academy.
  • As we recognize Mental Health Awareness Month each May, it enables Kellanova to underscore our priority commitment to employees' wellbeing by providing education and resources to support mental health.
  • Earlier this year, Kellanova added to its mental health toolkit by introducing Made Academy 2.0, an addition to the e-learning resource we began using in 2023.
  • This awareness month prompts important conversations about mental health disorders that can lead to self-diagnosis and self-identification that might otherwise never occur within demanding workplaces.

BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights

Retrieved on: 
Mittwoch, Mai 8, 2024

BURLINGTON, Mass. and JERUSALEM, May 08, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported first quarter 2024 financial results and provided an operational update.

Key Points: 
  • and JERUSALEM, May 08, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported first quarter 2024 financial results and provided an operational update.
  • For the three months ended March 31, 2024, revenues were $9.1 million, a 37% increase as compared to the first quarter of 2023.
  • Gross margin for the first quarter of 2024 was 75%, an increase from 73% in the first quarter of 2023.
  • Net income for the first quarter of 2024 was $0.1 million, compared to a net loss of $2.4 million for the first quarter of 2023.

Timothy Hill, Expert in Medicare, Medicaid, and Health Policy, Is New Leader of American Institutes for Research’s Health Division

Retrieved on: 
Montag, Mai 6, 2024

Hill is a recognized expert in the health policy community and a strong communicator who brings a solutions-oriented mindset to problem solving and policy development.

Key Points: 
  • Hill is a recognized expert in the health policy community and a strong communicator who brings a solutions-oriented mindset to problem solving and policy development.
  • He has deep knowledge of the policies and systemic operations of Medicare and Medicaid, including the Children’s Health Insurance Program (CHIP).
  • AIR’s Health Division studies and helps implement solutions to challenges facing the healthcare system and inequities in public health, both in the U.S. and internationally.
  • Hill, who has served as the interim leader of the Health Division since September 2023, began his new role on April 16.

Anthem Blue Cross and Blue Shield Expands Access to Mental Healthcare for Children with Addition of InStride Health to Network

Retrieved on: 
Dienstag, Mai 7, 2024

As part of Anthem Blue Cross and Blue Shield in Connecticut’s (Anthem) ongoing work to expand access to mental healthcare in the state, Anthem recently welcomed InStride Health, a specialty pediatric anxiety and obsessive-compulsive disorder (OCD) treatment provider, to its care provider network.

Key Points: 
  • As part of Anthem Blue Cross and Blue Shield in Connecticut’s (Anthem) ongoing work to expand access to mental healthcare in the state, Anthem recently welcomed InStride Health, a specialty pediatric anxiety and obsessive-compulsive disorder (OCD) treatment provider, to its care provider network.
  • “At Anthem Blue Cross and Blue Shield, we’re committed to a whole-health approach to our members’ care.
  • That’s why we’re thrilled to welcome InStride Health to Anthem’s expansive network in Connecticut,” said Lou Gianquinto, president of Anthem Blue Cross and Blue Shield in Connecticut.
  • “We also understand the unique healthcare landscape of Connecticut and are committed to meeting the specific needs of the community.

Project Lyme Harnesses the Power of Public Service Announcements to Inform Parents Their Child's Complex Illness Could Be Lyme

Retrieved on: 
Mittwoch, Mai 8, 2024

NEW YORK, May 8, 2024 /PRNewswire/ -- The CDC now estimates nearly half a million people will contract Lyme disease in the United States each year. However, most people do not realize how Lyme disease can cause diverse, devastating symptoms in some patients. The range of symptoms is expansive and often overwhelming, from flu-like symptoms such as fatigue, fever, enlarged lymph nodes, headaches, muscle aches, and joint pain in the early stages to more serious issues such as cognitive impairment, sleep problems, mood changes, shortness of breath or heart failure when a diagnosis is missed or delayed. Lyme has been reported in all 50 states, with case counts increasing throughout the country. As the risk of contracting a tick-borne infection increases nationally, it is imperative to educate a broader audience, especially parents of young children.

Key Points: 
  • However, most people do not realize how Lyme disease can cause diverse, devastating symptoms in some patients.
  • Children are at the greatest risk of contracting Lyme disease and delayed diagnosis can prevent them from living a normal life.
  • In their new PSAs , Project Lyme tells the stories of Rylyn and Pippa , two young children who are recovering from Lyme disease.
  • Project Lyme's PSAs provide advice that if you are unsure of the source of your child's illness, it could be Lyme.

May Is Maternal Mental Health Month; Postpartum Support International Urges Friends, Family to Check on New and Expectant Moms, Discuss Mental Health

Retrieved on: 
Mittwoch, Mai 1, 2024

PORTLAND, Ore., May 1, 2024 /PRNewswire/ -- May brings National Maternal Mental Health Month, World Maternal Mental Health Day (May 1), and Mother's Day (May 12), making it an ideal time to talk about perinatal mental health (PMH) and to educate mothers and the people in their lives about postpartum depression and other PMH disorders. Nonprofit Postpartum Support International (PSI) is working to improve PMH disorder awareness and access to free support and care while reducing stigma around perinatal mental health disorders.  

Key Points: 
  • Nonprofit Postpartum Support International (PSI) is working to improve PMH disorder awareness and access to free support and care while reducing stigma around perinatal mental health disorders.
  • Each May, PSI puts extra emphasis on educating the public during National Maternal Mental Health Month.
  • May is also when Americans celebrate mothers and motherhood, which is anything but joyful for those suffering from a PMH disorder.
  • Laundry, cooking or ordering takeout, and watching the baby so she can have time alone are all ways to provide support.

Relief Mental Health Sheds Light on Innovative Treatments During Mental Health Awareness Month

Retrieved on: 
Mittwoch, Mai 1, 2024

As Mental Health Awareness Month kicks off today, Relief Mental Health aims to spotlight innovative therapies that offer hope to individuals struggling with mental health diagnoses.

Key Points: 
  • As Mental Health Awareness Month kicks off today, Relief Mental Health aims to spotlight innovative therapies that offer hope to individuals struggling with mental health diagnoses.
  • "TMS, Spravato, and IV ketamine represent a new frontier in mental health treatment, offering relief to those who have struggled with traditional therapies,” said Teresa Poprawski, MD , a neuropsychiatrist and chief medical officer at Relief Mental Health.
  • In honor of Mental Health Month and to help educate the public on the benefits of TMS specifically, Relief Mental Health is hosting an Instagram Live event on Friday, May 17, at 10 a.m. central time.
  • For more information about Relief Mental Health or to schedule a consultation for any of its services, individuals can call 855.205.4764, email [email protected] or visit reliefmh.com .

United States Gluten-Free Food Products Market Insights 2024: A $4.25 Billion Industry by 2029, Driven by Rising Incidence of Intolerance & Increasing Availability of Diversified Options - ResearchAndMarkets.com

Retrieved on: 
Freitag, April 26, 2024

The U.S. gluten-free food products market is expected to reach a value of 4.25 billion by 2029 from $2.62 billion in 2023, growing at a CAGR of 8.36%

Key Points: 
  • The U.S. gluten-free food products market is expected to reach a value of 4.25 billion by 2029 from $2.62 billion in 2023, growing at a CAGR of 8.36%
    The U.S. gluten-free food products market report contains exclusive data on 28 vendors.
  • The US gluten-free food products market is highly competitive, with established players and emerging brands competing for market share.
  • The rising incidence of celiac disease and gluten intolerance is a major driver in the U.S. gluten-free food products market.
  • The increasing availability of diversified gluten-free food options is a key driver in the U.S. market, contributing to its ongoing growth.